Resources
UF researcher’s “mop up” malaria vaccine funded for trials in people
March 31, 2021: A malaria vaccine designed by UF professor Rhoel Dinglasan is expected to advance to phase 1 clinical trials, thanks to new funding. The vaccine is designed differently from all others: It immunizes mosquitoes via people.
Rhoel Dinglasan, Ph.D, M.P.H. and M.Phil., shown in his EPI laboratory. His home academic department is in UF's department of infectious diseases and immunology in the College of Veterinary Medicine. Photo by UF Health
University of Florida researcher Rhoel Dinglasan, Ph.D., was awarded $6 million today by the Global Health Innovative Technology Fund to test a new malaria vaccine in people. The process leading to a phase 1 clinical trial begins this April.